Home » Clinical Trials » Therapeutic Areas

Therapeutic Areas: Oncology | Hematology
Disease Category: Mantle Cell Lymphoma
Location: United States, ND

Clinical Trial Details


Research Study Summary

Newly Diagnosed Mantle Cell Lymphoma who are not eligible for a bone marrow transplant.


Newly Diagnosed Mantle Cell Lymphoma who are not eligible for a bone marrow transplant.

Patient Inclusion Criteria:

  • 18 + years of age,
  • diagnosis of MCL, at least 1 measurable site of disease, not eligible or not considered for bone marrow transplantation

Patient Exclusion Criteria:

  • Prior treatment with VELCADE, major surgery with 2 weeks before randomization, peripheral neuropathy or neuropathic pain, diagnosed or treated for a malignancy other than MCL within 1 year of randomization

To Learn more

CW ID: 163100
Date Last Changed: July 24, 2013

Clinical Trial Snapshot

Both Male and Female
18 and up
Overall Status
Facility Type


Dr. Tom Davis, Director of Business Development
Legacy Pharma Research
601 N. 5th St.
Bismarck, ND 58501
Phone: 701-751-1128
Fax: 701-751-1131

View Map

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.